Karyopharm Therapeutics Inc. Business Finance Contracts & Agreements

26 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Common Stock Purchase Warrant, dated August 1, 2023, issued to Heathcare Royalty Partners III, L.P
Warrant Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2023
Registration Rights Agreement, dated December 5, 2022, by and among the Company and the other parties thereto
Registration Rights Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2022
Securities Purchase Agreement, dated December 5, 2022, by and among the Company and the other parties thereto
Purchase Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2022
Form of Warrant to Purchase Common Stock to be issued pursuant to the Securities Purchase Agreement
Warrant Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2022
Amendment to Asset Purchase Agreement, dated as of July 17, 2019, by and between the Registrant and Biogen MA Inc
Purchase Agreements
Karyopharm Therapeutics Inc.
Biotechnology
2021
Form of Nonstatutory Stock Option Agreement for Inducement Grants adopted August 25, 2020
Stock Agreements
Karyopharm Therapeutics Inc.
Biotechnology
DE
2020
Underwriting Agreement, dated March 3, 2020, by and among the Company, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and Jefferies LLC
Underwriting Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2020
Revenue Interest Financing Agreement, dated September 14, 2019, between the Registrant and HealthCare Royalty Partners III, L.P, and HealthCare Royalty Partners IV, L.P
Financing Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2019
Nonstatutory Stock Option Agreement, dated February 25, 2019, between the Company and Michael Mason
Stock Agreements
Karyopharm Therapeutics Inc.
Biotechnology
DE
2019
Indenture (including form of Note) with respect to the Companys 3.00% convertible senior notes due 2025, dated as of October 16, 2018, between the Company and Wilmington Trust,...
Indenture Agreements
Karyopharm Therapeutics Inc.
Biotechnology
DE
2018
Parent Company Guarantee, dated May 23, 2018, by Antengene Corporation Co. Ltd
Guarantee Agreements
Karyopharm Therapeutics Inc.
Biotechnology
2018
Form of Nonstatutory Stock Option Agreement for Inducement Grants
Stock Agreements
Karyopharm Therapeutics Inc.
Biotechnology
DE
2018
Asset Purchase Agreement, dated January 24, 2018, by and between Biogen MA Inc. and the Registrant
Purchase Agreements
Karyopharm Therapeutics Inc.
Biotechnology
MA
2018
Underwriting Agreement, dated May 2, 2018, by and among the Company, J.P. Morgan Securities LLC, Jefferies LLC and Leerink Partners LLC
Underwriting Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2018
Nonstatutory Stock Option Agreement, dated September 11, 2017, between the Company and Mr. Falvey
Stock Agreements
Karyopharm Therapeutics Inc.
Biotechnology
DE
2017
KARYOPHARM THERAPEUTICS INC. (aDelaware corporation) 3,902,439 Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2017
KARYOPHARM THERAPEUTICS INC. Shares of Common Stock (par value$0.0001 per share) Controlled Equity OfferingSM Sales Agreement
Stock Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2015
KARYOPHARM THERAPEUTICS INC. RESTRICTED STOCK UNIT AGREEMENT
Stock Agreements
Karyopharm Therapeutics Inc.
Biotechnology
DE
2015
KARYOPHARM THERAPEUTICS INC. (aDelaware corporation) 3,000,000 Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2015
KARYOPHARM THERAPEUTICS INC. (a Delaware corporation) [ ] Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2014
KARYOPHARM THERAPEUTICS INC. 2013 EMPLOYEE STOCK PURCHASE PLAN October 8, 2013
Stock Agreements
Karyopharm Therapeutics Inc.
Biotechnology
DE
2013
KARYOPHARM THERAPEUTICS INC. NONSTATUTORY STOCK OPTION AGREEMENT
Stock Agreements
Karyopharm Therapeutics Inc.
Biotechnology
2013
KARYOPHARM THERAPEUTICS INC. (a Delaware corporation) Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2013
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. RESEARCH AGREEMENT
Exchange Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2013
KARYOPHARM THERAPEUTICS INC. NON-QUALIFIED STOCK OPTION AGREEMENT
Stock Agreements
Karyopharm Therapeutics Inc.
Biotechnology
MA
2013
KARYOPHARM THERAPEUTICS INC. THIRD AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT July 26, 2013
Investor Rights Agreements
Karyopharm Therapeutics Inc.
Biotechnology
MA
2013